Vapotherm Blog

Getting Through Flu Season — Tips for Clinicians

It’s that time of the year again. Flu Season and Respiratory Season are here and hospitals across the country are gearing up for the influx of patients streaming into their emergency departments.
It’s a hectic time each year, so we decided to ask some of the respiratory therapists, nurses, and physicians on our team what helped them get through it as smoothly as possible.

A Gentler Alternative to nCPAP in the NICU

Although nCPAP is the gold standard primary respiratory support for premature neonates, it also causes nasal injury in 20%-100% of that vulnerable population. This is quite a wide range as the prevalence of nasal injury varies and is based on multiple factors, including the baby’s gestational age and birth weight.

New Retrospective Study Adds to Body of Evidence that Vapotherm® High Velocity Therapy is Effective Primary Respiratory Support for Premature Neonates

In December 2018, Neonatology published the results of a multicenter, retrospective observational analysis conducted by Zivanovic and colleagues, titled “Nasal High-Flow Therapy as Primary Respiratory Support for Preterm Infants without the Need for Rescue with Nasal Continuous Positive Airway Pressure”.

When HFNC is Not Enough for Your Babies and Why High Velocity Therapy Could Help

A new multicenter randomized trial published in the New England Journal of Medicine demonstrated yet again that high flow nasal cannula (HFNC) is not a viable alternative to CPAP for primary respiratory support in neonates.

Maintain Full Respiratory Support on the Go — Five Things You Can Do When You Have the Freedom to Move Your Patients

Hi-VNI® Technology is a mask-free respiratory support tool as effective as NiPPV. As such, it already brings many benefits to a hospital — it simplifies care, allowing patients in undifferentiated respiratory distress to eat, drink, speak, and take oral medications while maintaining therapy.

The First Major NIV Innovation in the Past 30 Years is Here! — And It May Be a Solution for Anxious Respiratory Distress Patients

Let’s face it, tightly strapped face masks are not exactly pleasant. While many respiratory distress patients tolerate mask and pressure-based therapies just fine, many also experience anxiety and claustrophobia. Yet the gold standard treatment for patients in undifferentiated respiratory distress is Noninvasive Positive Pressure Ventilation (NiPPV), even though about a third of all NiPPV failure is due to mask-intolerance.

Could Your Hospital Save Money? The Economic Benefits of Ambulation

The medical community widely recognizes that prolonged bedrest can have harmful effects on patients while early mobility can lead to better outcomes. Yet, deep sedation of mechanically ventilated patients, and prolonged bed rest remain frequent practices in many ICUs.

How to Treat Respiratory Distress in Acute Decompensated Heart Failure Patients Without Using a Mask?

When it comes to treating patients with acute decompensated heart failure (ADHF), usually an exacerbation of congestive heart failure (CHF), non-invasive positive pressure ventilation (NiPPV) is often the go-to therapy. However, studies show that more than 30% of patients cannot tolerate NiPPV due to mask intolerance.

Subgroup Analysis Suggests HVNI Non-Inferior to NiPPV in Treatment of Acute Decompensated Heart Failure Patients

In March 2019, Haywood and colleagues published the results of a subgroup analysis in the American Journal of Emergency Medicine titled “HVNI vs NIPPV in the treatment of Acute Decompensated Heart Failure: subgroup analysis of a multi-center trial in the ED.”

What Spectrum of Patients Can Go On Hi-VNI® Technology? — An Emergency Physician Discusses

Hi-VNI Technology is Mask-Free NIV™ for spontaneously breathing patients, and as such it is a viable alternative to non-invasive positive pressure ventilation (NiPPV). It can be an especially useful tool in the Emergency Department (ED) where physicians don’t yet know what exactly is wrong with the patients, but have to treat their respiratory distress quickly.